ロード中...
Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanism
Despite manifold efforts to achieve reduced-intensity and -toxicity regimens, secondary leukemia has remained the most severe side effect of chemotherapeutic cancer treatment. Rearrangements involving a short telomeric <1 kb region of the mixed lineage leukemia (MLL) gene are the most frequently...
保存先:
| 出版年: | Front Cell Dev Biol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479792/ https://ncbi.nlm.nih.gov/pubmed/26161385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2015.00041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|